市場調查報告書
商品編碼
1541458
2024-2032 年按設備類型、最終用戶、配銷通路和地區分類的避孕器具市場報告Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2024-2032 |
2023年全球避孕器具市場規模達143億IMARC Group。人們對計劃生育重要性的認知不斷提高,意外懷孕的發生率不斷上升,以及政府為促進計劃生育項目而採取的舉措和資金不斷增加,這些都是推動市場發展的一些關鍵因素。
避孕器具是幫助個人和夫妻預防意外懷孕的重要工具。這些裝置透過抑制受精過程有效地防止懷孕。根據設備類型,它們採用各種材料和技術製成。屏障方法(例如保險套和隔膜)可防止精子到達卵子,通常由乳膠、聚氨酯 (PU) 或其他材料製成。荷爾蒙避孕藥,例如避孕藥、注射和貼片,含有合成激素,可以調節女性的月經週期並防止排卵。另一方面,子宮內避孕器 (IUD) 由銅或塑膠製成,插入子宮以防止懷孕。避孕器具具有許多優點,例如使個人能夠自主規劃其家庭並就其生殖健康做出明智的選擇。它們可供男性和女性使用,提供多種避孕選擇。如果正確使用,它們通常是安全有效的,而且許多設備還提供額外的好處,例如預防性傳染病 (STI) 或減少月經出血。
全球避孕器具市場由多種因素推動,包括人們對計劃生育方法的認知和採用不斷提高,以及意外懷孕發生率的增加。此外,政府為促進計劃生育計劃而採取的措施和資金不斷增加,以及性傳染感染的盛行率激增,都推動了市場的成長。此外,各種避孕器具(包括口服避孕藥、子宮內避孕器、保險套和皮下埋植劑)的供應以及消費者支出能力的增加正在推動市場成長。除此之外,長效可逆避孕藥的開發、電子商務領域的擴張以及產品創新的不斷成長趨勢正在推動市場的成長。與此一致的是,對非荷爾蒙和天然避孕藥的需求不斷成長以及對女性控制避孕方法的接受度激增也促進了市場的成長。其他因素,例如製造商和醫療保健提供者之間的夥伴關係和合作數量不斷增加,以及新興市場分銷網路的擴張,預計將進一步推動市場成長。
The global contraceptive devices market size reached US$ 14.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The increasing awareness about the importance of family planning, the growing incidence of unintended pregnancies, and the rising government initiatives and funding to promote family planning programs represent some of the key factors driving the market.
Contraceptive devices are essential tools that help individuals and couples prevent unintended pregnancies. These devices effectively prevent pregnancy by inhibiting the fertilization process. They are made using various materials and technologies, depending on the type of device. Barrier methods, such as condoms and diaphragms, prevent sperm from reaching the egg and are typically made of latex, polyurethane (PU), or other materials. Hormonal contraceptives, such as birth control pills, injections, and patches contain synthetic hormones that regulate the woman's menstrual cycle and prevent ovulation. On the other hand, intrauterine devices (IUDs) are made of either copper or plastic and are inserted into the uterus to prevent pregnancy. Contraceptive devices offer numerous advantages, such as providing individuals with the autonomy to plan their families and make informed choices about their reproductive health. They can be used by both men and women, offering a wide range of options for contraception. They are generally safe and effective when used correctly, and many devices also provide additional benefits, such as protection against sexually transmitted infections (STIs) or reduced menstrual bleeding.
The global contraceptive devices market is driven by several factors, including the increasing awareness and adoption of family planning methods and the growing incidence of unintended pregnancies. Moreover, the rising government initiatives and funding to promote family planning programs and the surging prevalence of STIs are boosting the market growth. Furthermore, the availability of various contraceptive devices, including oral contraceptives, intrauterine devices, condoms, and subdermal implants, and inflating consumer expenditure power are driving the market growth. Apart from this, the development of long-acting reversible contraceptives, the expansion of the e-commerce sector, and the inflating trend of product innovations are fueling the market growth. In line with this, the increasing demand for non-hormonal and natural contraceptives and the surging acceptance of female-controlled contraceptive methods are also contributing to the market growth. Other factors, such as the growing number of partnerships and collaborations between manufacturers and healthcare providers, as well as the expansion of distribution networks in emerging markets, are expected to propel the market growth further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, end user and distribution channel.
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUDs
Others
The report has provided a detailed breakup and analysis of the contraceptive devices market based on the device type. This includes condoms, diaphragms, cervical caps, sponges, vaginal rings, IUDs, and others. According to the report, condoms accounted for the largest market share.
Male
Female
A detailed breakup and analysis of the contraceptive devices market based on the end user has also been provided in the report. This includes male and female. According to the report, males accounted for the largest market share.
Hospital Pharmacies
Retail Pharmacies
Online Stores
Others
A detailed breakup and analysis of the contraceptive devices market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, retail pharmacies accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for contraceptive devices. Some of the factors driving the North America contraceptive devices market included increasing awareness and acceptance, technological advancements, government initiatives, and rising prevalence of STIs.
The report has also provided a comprehensive analysis of the competitive landscape in the global contraceptive devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Allergan plc, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Merck & Co., Mylan Inc., Pfizer Inc., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., and The Female Health Company. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.